Artanomaloide is primarily used in pharmaceutical research due to its potential bioactive properties. It has shown promise as an anti-inflammatory agent in preclinical studies, making it a candidate for development in treatments targeting chronic inflammatory diseases such as heart disease and diabetes. Additionally, it exhibits antioxidant activity, which may contribute to cellular protection against oxidative stress. Preliminary research indicates it inhibits the growth of cancer cells, particularly in breast and colon cancer models. Researchers are also exploring its role in neuroprotective therapies, as early studies suggest it may help mitigate neurodegenerative processes. Its applications extend to dietary supplements and cosmetics, where it supports skin care and anti-aging by protecting against UV damage and pollution. Its natural origin and structural complexity make it valuable in the design of novel therapeutic agents and in understanding biological pathways related to aging and immune response.